Copenhagen, Denmark; August 5, 2002 - Genmab A/S (CSE: GEN and Neuer Markt: GE9D) announced today the appointment of Jørgen Petersen, DMSc as Medical Director. As an integral part of Genmab's clinical team, Dr. Petersen will provide valuable input to the company's drug development plans and utilize his broad experience to identify potentially interesting drug targets for future development work. Dr Petersen joins Genmab from November 1st 2002

Dr. Petersen is currently Head of the Rheumatology Clinic, The Finsen Center at Rigshopitalet in Copenhagen, where he is responsible for diagnosis and treatment of advanced cases of rheumatoid arthritis, connective tissue disorders and vasculitis. He is also in charge of the clinic's experimental and clinical research program. In parallel with his clinical career, Dr. Petersen has served as associate and full Professor of Internal Medicine at the University of Copenhagen.

Dr. Petersen has extensive international experience from his time as a post-doctoral fellow of Molecular and Experimental Medicine at the Institute of Scripps Clinic in La Jolla, California, where he worked with models for T-cell immunity in RA. Dr Petersen is also trained as a cellular immunologist and has authored around 100 publications within the fields of rheumatology, cellular immunology, inflammation, and immunopharmacology.

"We are extremely pleased that Jørgen Petersen can bring his wealth of experience to Genmab's clinical team," said Lisa N. Drakeman, Ph.D., Chief Executive Officer of Genmab. "Dr Petersen's skills and knowledge in the diagnosis and treatment of rheumatoid arthritis will ensure he plays a key role in Genmab's efforts to build a broad pipeline of therapeutic products.